Netherlands· NL-02b3bd40df9f

Depakine vloeistof voor kinderen, vloeistof voor oraal gebruik 300 mg/ml

A valproic acid product containing natriumvalproaat, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC N03AG01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about natriumvalproaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Valproic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AG01 (valproic acid), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search valproic acid products by name

Valproic acid · ATC N03AG01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valproic acid costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Valproic acid · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

CH Switzerland$1.61

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: NATRIUMVALPROAAT
Manufacturer: Euro Registratie Collectief B.V.
Country: Netherlands (NL)
ATC code: N03AG01
ATC class: Valproic acid
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
119797//17569

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

391 interactions on record for valproic acid.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check valproic acid against other medicines How interaction checks work

Valproic acid · interactions on record

391 records

9 severe
132 moderate
23 minor
189 info

Most severe, free to view

Glycerol phenylbutyrateA16AX09severe
BexaroteneL01XF03severe
VorinostatL01XH01severe
BexarotenL01XX25severe

38 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valproic acid in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valproic acid products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

Austria · Convulex
Bulgaria · Convulex, Конвулекс
Czechia · Convulex
Germany · Convulex
Estonia · Convulex
United Kingdom (Northern Ireland) · Convulex
Hungary · Convulex
Lithuania · Convulex
Latvia · Convulex
Poland · Convulex, Convulex 150
Portugal · Ácido Valpróico Generis
Romania · Convulex
Slovakia · Convulex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/268b4c6a-470f-4268-b306-f0842e87d9ef
GET /v1/drugs/268b4c6a-470f-4268-b306-f0842e87d9ef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Vloeistof voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h17569_smpc.pdf",
  "strength": null,
  "atc_label": "Valproic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg119797",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "SINAASAPPELAROMA 30 F 27",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "NATRIUMVALPROAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h119797.pdf",
  "authorised_at": "2016/12/01",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "119797//17569",
  "additional_monitoring": "Y"
}

API reference MCP server Plans

See everything about valproic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console